Pavel P. Kuksa

Dr. Pavel P. Kuksa


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
YLYuk Yee Leung
Yuk Yee Leung
PKPavel P. Kuksa
Pavel P. Kuksa
AAAlexandre Amlie-Wolf
Alexandre Amlie-Wolf
OVOtto Valladares
Otto Valladares
LULyle H. Ungar
Lyle H. Ungar
LWLi-San Wang
Li-San Wang
Small non-coding RNAs (sncRNAs) are highly abundant RNAs, typically <100 nucleotides long, that act as key regulators of diverse cellular processes. Although thousands of sncRNA genes are known to exist in the human genome, no single database provides searchable, unified annotation, and expression information for full sncRNA transcripts and mature RNA products derived from these larger RNAs. Here, we present the Database of small human noncoding RNAs (DASHR). DASHR contains the most comprehensive information to date on human sncRNA genes and mature sncRNA products. DASHR provides a simple user interface for researchers to view sequence and secondary structure, compare expression levels, and evidence of specific processing across all sncRNA genes and mature sncRNA products in various human tissues. DASHR annotation and expression data covers all major classes of sncRNAs including microRNAs (miRNAs), Piwi-interacting (piRNAs), small nuclear, nucleolar, cytoplasmic (sn-, sno-, scRNAs, respectively), transfer (tRNAs), and ribosomal RNAs (rRNAs). Currently, DASHR (v1.0) integrates 187 smRNA high-throughput sequencing (smRNA-seq) datasets with over 2.5 billion reads and annotation data from multiple public sources. DASHR contains annotations for ∼48 000 human sncRNA genes and mature sncRNA products, 82% of which are expressed in one or more of the curated tissues. DASHR is available at http://lisanwanglab.org/DASHR.

10 November 2009 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
PKPavel P. Kuksa
Pavel P. Kuksa
VPVladimir Pavlovic
Vladimir Pavlovic
In this work we consider barcode DNA analysis problems and address them using alternative, alignment-free methods and representations which model sequences as collections of short sequence fragments (features). The methods use fixed-length representations (spectrum) for barcode sequences to measure similarities or dissimilarities between sequences coming from the same or different species. The spectrum-based representation not only allows for accurate and computationally efficient species classification, but also opens possibility for accurate clustering analysis of putative species barcodes and identification of critical within-barcode loci distinguishing barcodes of different sample groups.

9 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KFKurt Farrell
Kurt Farrell
JHJack Humphrey
Jack Humphrey
TCTimothy Chang
Timothy Chang
YZYi Zhao
Yi Zhao
YLYuk Yee Leung
Yuk Yee Leung
ANAdam Naj
Adam Naj
Progressive supranuclear palsy (PSP), a rare Parkinsonian disorder, is characterized by problems with movement, balance, and cognition. PSP differs from Alzheimer’s disease (AD) and other diseases, displaying abnormal microtubule-associated protein tau by both neuronal and glial cell pathologies. Genetic contributors may mediate these differences; however, the genetics of PSP remain underexplored. Here we conduct the largest genome-wide association study (GWAS) of PSP which includes 2779 cases (2595 neuropathologically-confirmed) and 5584 controls and identify six independent PSP susceptibility loci with genome-wide significant (P < 5 × 10−8) associations, including five known (MAPT, MOBP, STX6, RUNX2, SLCO1A2) and one novel locus (C4A). Integration with cell type-specific epigenomic annotations reveal an oligodendrocytic signature that might distinguish PSP from AD and Parkinson’s disease in subsequent studies. Candidate PSP risk gene prioritization using expression quantitative trait loci (eQTLs) identifies oligodendrocyte-specific effects on gene expression in half of the genome-wide significant loci, and an association with C4A expression in brain tissue, which may be driven by increased C4A copy number. Finally, histological studies demonstrate tau aggregates in oligodendrocytes that colocalize with C4 (complement) deposition. Integrating GWAS with functional studies, epigenomic and eQTL analyses, we identify potential causal roles for variation in MOBP, STX6, RUNX2, SLCO1A2, and C4A in PSP pathogenesis.

3 August 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AAAlexandre Amlie-Wolf
Alexandre Amlie-Wolf
MTMitchell Tang
Mitchell Tang
EMElisabeth E Mlynarski
Elisabeth E Mlynarski
PKPavel P. Kuksa
Pavel P. Kuksa
OVOtto Valladares
Otto Valladares
LWLi-San Wang
Li-San Wang
The majority of variants identified by genome-wide association studies (GWAS) reside in the noncoding genome, affecting regulatory elements including transcriptional enhancers. However, characterizing their effects requires the integration of GWAS results with context-specific regulatory activity and linkage disequilibrium annotations to identify causal variants underlying noncoding association signals and the regulatory elements, tissue contexts, and target genes they affect. We propose INFERNO, a novel method which integrates hundreds of functional genomics datasets spanning enhancer activity, transcription factor binding sites, and expression quantitative trait loci with GWAS summary statistics. INFERNO includes novel statistical methods to quantify empirical enrichments of tissue-specific enhancer overlap and to identify co-regulatory networks of dysregulated long noncoding RNAs (lncRNAs). We applied INFERNO to two large GWAS studies. For schizophrenia (36,989 cases, 113,075 controls), INFERNO identified putatively causal variants affecting brain enhancers for known schizophrenia-related genes. For inflammatory bowel disease (IBD) (12,882 cases, 21,770 controls), INFERNO found enrichments of immune and digestive enhancers and lncRNAs involved in regulation of the adaptive immune response. In summary, INFERNO comprehensively infers the molecular mechanisms of causal noncoding variants, providing a sensitive hypothesis generation method for post-GWAS analysis. The software is available as an open source pipeline and a web server.

23 August 2018 in Bioinformatics
Verified
Journal Article
Open access
PDF file
PKPavel P. Kuksa
Pavel P. Kuksa
AAAlexandre Amlie-Wolf
Alexandre Amlie-Wolf
ŽKŽivadin Katanić
Živadin Katanić
OVOtto Valladares
Otto Valladares
LWLi-San Wang
Li-San Wang
YLYuk Yee Leung
Yuk Yee Leung
Small non-coding RNAs (sncRNAs, 800 curated experiments from ENCODE and GEO/SRA across multiple RNA-seq protocols for both GRCh38/hg38 and GRCh37/hg19 assemblies are integrated in DASHR. Moreover, DASHR is the first to contain both known and novel, previously un-annotated sncRNA loci identified by unsupervised segmentation (13 times more loci with 1 678 800 total). Additionally, DASHR v2.0 adds >3 200 000 annotations for non-small RNA genes and other genomic features (long-noncoding RNAs, mRNAs, promoters, repeats). Furthermore, DASHR v2.0 introduces an enhanced user interface, interactive experiment-by-locus table view, sncRNA locus sorting and filtering by biological features. All annotation and expression information directly downloadable and accessible as UCSC genome browser tracks. DASHR v2.0 is freely available at https://lisanwanglab.org/DASHRv2. Supplementary data are available at Bioinformatics online.

4 December 2014 in Bioinformatics
Verified
Journal Article
Open access
PDF file
YHYih-Chii Hwang
Yih-Chii Hwang
CLChiao-Feng Lin
Chiao-Feng Lin
OVOtto Valladares
Otto Valladares
JMJohn Malamon
John Malamon
PKPavel P. Kuksa
Pavel P. Kuksa
LWLi-San Wang
Li-San Wang
Summary: We implemented a high-throughput identification pipeline for promoter interacting enhancer element to streamline the workflow from mapping raw Hi-C reads, identifying DNA–DNA interacting fragments with high confidence and quality control, detecting histone modifications and DNase hypersensitive enrichments in putative enhancer elements, to ultimately extracting possible intra- and inter-chromosomal enhancer–target gene relationships. Availability and implementation: This software package is designed to run on high-performance computing clusters with Oracle Grid Engine. The source code is freely available under the MIT license for academic and nonprofit use. The source code and instructions are available at the Wang lab website (http://wanglab.pcbi.upenn.edu/hippie/). It is also provided as an Amazon Machine Image to be used directly on Amazon Cloud with minimal installation. Contact:lswang@mail.med.upenn.edu or bdgregor@sas.upenn.edu Supplementary information: Supplementary Material is available at Bioinformatics online.